Lung disease medicine, ‘PNEUMOSTEM’ was designated as ‘Orphan Drug’ in Europe2015/07/06STEM CELL THERAPEUTIC
Participation in Biotec Japan and local publicity activities on CARTISTEM2015/05/13STEM CELL THERAPEUTIC
The only Korean company invited to North American Rare Medicine conference2015/04/24STEM CELL THERAPEUTIC
Administration of lung disease medicine ‘PNEUMOSTEM’ in clinical trial completed2015/04/15STEM CELL THERAPEUTIC
Administration of lung disease medicine ‘PNEUMOSTEM’ started in U.S. clinical trial2015/03/25STEM CELL THERAPEUTIC
43% Increase in Dosage of CARTISTEM, for 4th Quarter of 2014 Year on Year2014/12/30STEM CELL THERAPEUTIC
